The amounts of succinyl-CoA-3-oxo acid CoA-transferase (EC 2.8.3.5) decrease progressively in skeletal muscle in streptozotocin-diabetic rats, reaching after 10 days about 50% of the value in normal rat muscle. Electrofocusing studies indicate the occurrence of partial proteolysis of the enzyme in diabetic muscle. However, several functional parameters relating to acetoacetate utilization, including substrate inhibition, are quite similar for muscle transferase preparations from normal and diseased rats. The development of pathological ketoacidosis is discussed in the light of these observations.
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The amounts of succinyl-CoA-3-oxo acid CoA-transferase (EC 2.8.3.5) decrease progressively in skeletal muscle in streptozotocin-diabetic rats, reaching after 10 days about 50% of the value in normal rat muscle. Electrofocusing studies indicate the occurrence of partial proteolysis of the enzyme in diabetic muscle. However, several functional parameters relating to acetoacetate utilization, including substrate inhibition, are quite similar for muscle transferase preparations from normal and diseased rats. The development of pathological ketoacidosis is discussed in the light of these observations.
Previous studies in our laboratory (Fenselau & Wallis, 1974a) revealed the existence of substrate inhibition by acetoacetate of succinyl-CoA*-3-oxo acid CoA-transferase (EC 2.8.3.5), an initiator of ketone-body utilization in extrahepatic tissue. This effect, observed with enzyme preparations from heart, kidney, brain and skeletal muscle from normal adult rats, has not been studied for CoA-transferases from tissues of diabetic animals, where such an inhibition could contribute to the apparently impaired tissue utilization of ketone bodies in these animals and to their development of pathological ketosis (Beatty et al., 1960; Balasse & Havel, 1971; Bates, 1972; Bassler et al., 1973; Ruderman & Goodman, 1974) . We have focused our studies on skeletal-muscle CoAtransferase in diabetic rats, because skeletal muscle is the major consuming tissue for ketone bodies (Bassler et al., 1973) and because uncertainty exists about the extent of transferase activity in chronically diabetic rat muscle (Bassler et al., 1973; Williamson et al., 1971 The procedures described previously (Fenselau & Wallis, 1974b; Fenselau et al., 1975) were followed in order to obtain a total homogenate of hindquarter skeletal muscle in either 0.02M-potassium phosphate (pH7.0) or a Tris/KCl solution (pH7.4) containing 50mM-Tris/HCI, 0.1 M-KCI, 5mM-MgSO4, 1 mM-ATP and 1 mM-EDTA. The CoA-transferase activity in the phosphate medium, when necessary, could be concentrated by batchwise adsorption of the enzyme on alumina C, gel (Bio-Rad Laboratories, Richmond, CA, U.S.A.), followed by elution with a smaller volume of 0.25M-potassium phosphate (pH8.0). Protein concentrations were determined by the method of Lowry et al. (1951) , with bovine serum albumin as standard.
Muscle mitochondria were isolated by the procedure of Max et al. (1972) in a medium containing lOmM-Tris/HCl (pH7.4), 70mM-sucrose, 0.21 Mmannitol and O.1mM-EDTA. Uptake of 02 in the presence and absence of acetoacetate was measured as previously described (Fenselau & Wallis, 1974b) . Determination of enzyme kinetic and molecular properties Spectrophotometric measurements of CoA-transferase activity were made by detecting the formation of the Mg2+-acetoacetyl-CoA complex by using the conditions described in detail elsewhere (Fenselau & Wallis, 1974b,c) . Crude CoA-transferase in the total A. FENSELAU AND K. WALLTS muscle homogenate was electrofocused on a 1 lOmlcapacity isoelectric-focusing apparatus (LKB, Rockville, MD, U.S.A.), by using procedures described previously (Fenselau & Wallis, 1974b; Fenselau etal., 1975) .
Chemicals
All purchased chemicals were the highest purity available. fi-Hydroxybutyrate dehydrogenase (EC 1.1.1.30) was obtained from Sigma Chemical Co.
(St. Louis, MO, U.S.A.).
Results
CoA-transferase activities in the total homogenates of skeletal muscle from normal, 48h-starved, shortterm (2-4 days) diabetic and long-term (over 4 days) diabetic rats were 6.84±0.44, 7.02±0,5&, 4.36±0.82 and 3.19±0.31umol of acetoacetate formed/min per g wet wt. of tissue respectively. These values are averages (±S.E.M.) of duplicate measurements on four to six different preparations. No diffreces were found in the amounts of enzyme activity in musle from normal and starved rats. However, in the diabetic animals' mnscle, CoA-transferase activity decreased progressively with time after the streptozotocin injection, reaching after 10 days a value of less than half of the specific activity measured in the skeletal muscle of the normal animal.
The use of different homognizatio media (potassham phosphate or Tris/KCl soutions) did not alter the results. These meia were selkted because CoAtransferase activity is generally more stable in a phosphate buffer (Fenselau & Wallis, 1974b ) and the previously reported decrease in muscle transferase activity in diabetic rats was determined in a Tris/KCl buffer (Bissler et al., 1973) . Also, the presence of a mixture of various proteinase inhibitors [10mM-toluenesulphonyl fluoride, 2.8 mm-I-chloro4phenyl-3-L-tosylamidobutan-2-one (TPCK) or -7-amino-ichloro-3-L-tosylamidoheptan-2-one (TLCK)] in the homogenization medium did not lead to any increase in total transferase activity. No further decrease in activity was noted for solutions containing muscle CoA-transferase from normal or diabetic animals that wer kept at 4'C over 6h. Thus transferase activity in skeletal muscle did decrease during the course of diabetes (in rats where no effort is made to maintain the animal on insulin) and this decrease was not due to proteolysis occurring as an artifact in the homogenization medium after cell lysis.
Several kinetic properties of muscle transferases from normal and long-term-diabetic rats were determined in order to compare these tissues' abilities to consunme acetoacetate. The enzymes from both sources manifest the expected Ping Pong kinetic patterns and product inhibition by succinate that is competitive with respect to acetoacetate (Hersh & (Fenselau & Walli, 1974a) was also shown by both enzyme preparations, each revealing an inversion conoentration of about n5mm-acetoacetate (corresponding to the concentration at the point of intersection for the two lines in Fig. 1 ). Similar effects were also observed with intact mitochondria from normal and diabetic rat skeletal muscle, the major difference being that in both cases inversion concentrations were significantly lower with mitochondria (about 0.75 mmacetoacetate). Thus it appears that the enzyme-kinetic effect of substrate inhibition is manifested by intact mitochondria in acetoacetate oxidation.
Only one physical property of the transferases, namely the isoelectric point(s) of the active species, was examined in detail for the muscle transferases. Isoelectric focusing of the crude transferase preparations revealed distinctly different patterns for the enzymes fromn normal and long-term-diabetic rat skeletal muscle. The predominant active form (88 %) ofthe enzyme from normal animals has pl 7.4; a lesser species is found with pl6.8. For CoA-transferase preparations from diabetic animals, the active species were detected with pl values of 7.4 (69 %), 6.8 (23 %) trypsin decreased transferase activity to respectively 73 and 76% of the initial activity and shifted the pl value of the major active species in each of the treated preparations to 6.9 and 6.6 respectively. These observations suggest that the minor active species in the preparation from diabetic skeletal muscle are products of limited degradation of the enzyme and not different isoenzymic forms.
Discussion
The skeletal muscle of diabetic rats untreated with insulin, compared with normal tissue, contained less CoA-transferase activity after only several days, confirming the observation by Bissler et al. (1973) . This decrease in activity is accompanied with a slight change in CoA-transferase protein composition detected by electrofocusing: the new active components of the mixture most probably arise from proteolysis within the cell during the diabetic period. The loss of enzyme activity therefore appears to be only one specific example of the general degradation of muscle tissue that is occurring in these animals.
This CoA-transferase mixture from the diabetic animals, two-thirds of which was the same in electrofocusing experiments as the major species obtained from muscle ofnormal rats, displayed the same kinetic properties as the enzyme isolated from normal rat muscle. That is, the values of the Km for acetoacetate, Ki for succinate as a competitive product inhibitor and inversion concentration for acetoacetate as a substrate inhibitor are quite similar for enzyme preparations from normal and diabetic skeletal muscle. Substrate inhibition by acetoacetate was shown not only by preparations of muscle CoA-transferase but also by isolated muscle mitochondria; however, the inversion concentration for intact mitochondria, i.e. the concentration of acetoacetate where inhibition becomes evident in the Hill plot, is one-seventh of that in the enzyme preparations. A similar effect has been noted with mitochondria from rat kidney (Fenselau & Wallis, 1974a) and rat heart (A. Fenselau & K. Wallis, unpublished work) . The lower inversion concentration for intact mitochondria may well be explained by the ability of mitochondria to transport and accumulate internally anions by a process that requires a pH difference across the mitochondrial membrane and possibly the existence of specific carriers (Klingenberg, 1970) . It has been demonstrated that 8-hydroxybutyrate and acetoacetate are transported by the carrier involved in pyruvate translocation (Mowbray, 1975; Paradies & Papa, 1975) . In any event the occurrence of this or a similar concentrating effect permits this kinetic feature of CoA-transferase, namely substrate inhibition, to be operable under ketotic conditions in the rat and to play a role in controlling ketone-body metabolism.
Regulation of ketone-body metabolism in starved and diabetic rats, particularly with regard to the role of CoA-transferase, may be summarized as follows. In starvation the regulated fall in blood concentrations of insulin leads to increases in liver ketogenesis and in blood concentrations of ketone bodies. The plasma concentrations of ketone bodies reach a plateau, owing in part to the operation of the substrate inhibition by acetoacetate of CoA-transferase. This enzyme effect requires a diminished peripheral utilization of ketone bodies and their accumulation in the blood beginning at an approximate total concentration of 1 mm. Although several mechanisms by which ketone bodies feedback-inhibit their own production may normally be operable (e.g. effects on liver redox state and anti-lipolytic effects on adipose tissue) (for review, see Newsholme & Start, 1973) , in diabetic animals the physiological interactions between ketone bodies and insulin become most significant. Ketone bodies, particularly acetoacetate, on the basis of studies in rats (Hawkins et al., 1971; Malaisse & Malaisse-Lagae, 1968 ) and dogs (Madison et al., 1964) , can increase plasma insulin concentration, thereby decreasing fatty acid mobilization from adipose tissue and inhibiting ketogenesis. A deficiency in this process arises in diabetic rats, owing to the destruction of pancreatic a-cell function by selective streptozotocin treatment (Junod et al., 1969) . With the loss of insulin inhibition of ketogenesis, blood concentrations of ketone bodies continue to rise (past the plateau observed under starvation conditions) until the limits of renal clearance are reached.
In summary, the efficiency of extrahepatic tissues in utilizing ketone bodies is decreased in the short-termdiabetic rat compared with the starved rat, because blood concentrations of ketone bodies have attained values high enough for the display of a severe acetoacetate substrate-inhibitory effect on the CoA-transferase in these tissues. For the long-term-diabetic rat this grave situation is further exacerbated by decreases in muscle mass and muscle CoA-transferase content, with a consequent further decrease in ketone-body consumption.
